Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tami L Bair

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 1, 2020
A novel, rapid, and low cost method for preparing tissues with metallic stents for routine histologyDylan V Miller, Tyler A Jensen, Tami L Bair, et al.
Circulation. Cardiovascular Genetics|December 4, 2009
Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery diseaseBenjamin D Horne, John F Carlquist, Joseph B Muhlestein, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2020
The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary DiseaseBenjamin D Horne, Matthew J Hegewald, Courtney Crim, et al.
American Heart Journal|September 14, 2002
Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary interventionBenjamin D Horne, Joseph B Muhlestein, Gunnar G Strobel, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 16, 2009
Lack of association of tegaserod with adverse cardiovascular outcomes in a matched case-control studyJeffrey L Anderson, Heidi T May, Tami L Bair, et al.
The American Journal of Medicine|January 30, 2004
Effect of folic acid fortification of food on homocysteine-related mortalityJeffrey L Anderson, Kurt R Jensen, John F Carlquist, et al.
Journal of Cardiovascular Pharmacology|February 22, 2020
Predictors of Statin Intolerance in Patients With a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Health Care Institution: The IMPRES StudyTami L Bair, Heidi T May, Kirk U Knowlton, et al.
The American Journal of Cardiology|January 17, 2002
Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarctionJames S Zebrack, Jeffrey L Anderson, Chloe Allen Maycock, et al.
Journal of Clinical Medicine|August 26, 2022
Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World ExperienceJeffrey L Anderson, Viet T Le, Tami L Bair, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 30, 2021
<i>E</i>valuation of T<i>R</i>eatment With <i>A</i>ngiotensin <i>C</i>onverting <i>E</i>nzyme Inhibitors and the <i>R</i>isk of Lung Cancer: ERACER-An Observational Cohort StudyJeffrey L Anderson, Kirk U Knowlton, J Brent Muhlestein, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 1, 2020
A novel, rapid, and low cost method for preparing tissues with metallic stents for routine histologyDylan V Miller, Tyler A Jensen, Tami L Bair, et al.
Circulation. Cardiovascular Genetics|December 4, 2009
Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery diseaseBenjamin D Horne, John F Carlquist, Joseph B Muhlestein, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2020
The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary DiseaseBenjamin D Horne, Matthew J Hegewald, Courtney Crim, et al.
American Heart Journal|September 14, 2002
Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary interventionBenjamin D Horne, Joseph B Muhlestein, Gunnar G Strobel, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 16, 2009
Lack of association of tegaserod with adverse cardiovascular outcomes in a matched case-control studyJeffrey L Anderson, Heidi T May, Tami L Bair, et al.
The American Journal of Medicine|January 30, 2004
Effect of folic acid fortification of food on homocysteine-related mortalityJeffrey L Anderson, Kurt R Jensen, John F Carlquist, et al.
Journal of Cardiovascular Pharmacology|February 22, 2020
Predictors of Statin Intolerance in Patients With a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Health Care Institution: The IMPRES StudyTami L Bair, Heidi T May, Kirk U Knowlton, et al.
The American Journal of Cardiology|January 17, 2002
Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarctionJames S Zebrack, Jeffrey L Anderson, Chloe Allen Maycock, et al.
Journal of Clinical Medicine|August 26, 2022
Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World ExperienceJeffrey L Anderson, Viet T Le, Tami L Bair, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 30, 2021
<i>E</i>valuation of T<i>R</i>eatment With <i>A</i>ngiotensin <i>C</i>onverting <i>E</i>nzyme Inhibitors and the <i>R</i>isk of Lung Cancer: ERACER-An Observational Cohort StudyJeffrey L Anderson, Kirk U Knowlton, J Brent Muhlestein, et al.
Pageof 14